Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Tue, 13.08.2024
SGT German Private Equity GmbH & Co. KGaA
+++ Press release +++
SGT German Private Equity acquires three internet payment service providers and becomes a listed, strongly growing and profitable FinTech company
Acquisition of majority shareholdings for cash and transfer of treasury shares at a valuation of 2.40 EUR per SGT German Private Equity share
The new group plans a transactio [ … ]
Tue, 13.08.2024
Hardman & Co Research
Hardman & Co Research on Surface Transforms (SCE):
Pre-close trading, AGM and prospects
Surface Transforms (SCE) is delivering its £390m order book but still faces headwinds. It is knocking down the obstacles, giving detailed explanation of progress, and, indeed, output has been consistently good since late June. Clearly, this is not as ea [ … ]
Tue, 13.08.2024
JP Jenkins Ltd
13th Aug 2024
JPJ: DEST
ISIN: GB00BDHSP575
Destiny Pharma plc
("Destiny Pharma" or "the Company")
Shares now trading on JP Jenkins
London, UK, 13th Aug 2024 - Destiny Pharma plc (JPJ: DEST), a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening in [ … ]
Tue, 13.08.2024
USU Software AG
Moeglingen, August 13, 2024.
USU has won a project tendered by the Technical University of Braunschweig to implement a central Software Asset Management (SAM) solution. The system will be operated as Software-as-a-Service (SaaS) in USU's own data center in Aachen.
The medium-term goal of TU Braunschweig is to establish a holistic IT Asset Managem [ … ]
Tue, 13.08.2024
Eckert & Ziegler SE
Berlin, August 13, 2024 - Eckert & Ziegler and Telix Pharmaceuticals Limited (Telix) today announced the signing of a significant multi-year agreement under which Eckert & Ziegler will serve as the European contract manufacturing organization (CMO) for Telix's ProstACT GLOBAL Phase III study. The contract covers the supply of the entire Eur [ … ]
Tue, 13.08.2024
clearvise AG
clearvise AG publishes half-year financial report 2024 and confirms outlook
Group revenue reaches EUR 18.9 million in the first half of 2024
Adjusted EBITDA amounts to EUR 12.4 million
Total production amounted to 234.4 GWh; share of PV production increases significantly
Outlook for the current financial year 2024 confirmed
Frankfurt, 13 Augus [ … ]
Tue, 13.08.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC USOTC: DTCFF PRESS RELEASE
DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES
Vancouver, BC, Canada, August 13th, 2024 - Defence Therapeutics Inc. (“Defence” or [ … ]
Tue, 13.08.2024
secunet Security Networks AG
secunet Security Networks AG publishes Half-Year Financial Report 2024 and confirms forecast for the full year
[Essen, Germany, 13 August 2024] secunet Security Networks AG (ISIN DE0007276503, WKN 727650), Germany's leading cybersecurity company and IT security partner of the Federal Republic of Germany, today published its Half-Year Financial Rep [ … ]
Tue, 13.08.2024
CANCOM SE
Group revenues increase by 29.1 percent to € 835.3 million in H1 2024
EBITDA reaches € 55.5 million after € 41.6 million in the same period of the prior year
Operating cash flow of € 68.6 million in the first half of the year still well above the prior year's figure
Forecast for the financial year confirmed by the Executive Board
Munich, Germany [ … ]
Tue, 13.08.2024
JP Jenkins Ltd
13th Aug 2024
JPJ: DEST
ISIN: GB00B60BD277
Destiny Pharma plc
("Destiny Pharma" or "the Company")
Shares now trading on JP Jenkins
London, UK, 13th Aug 2024 - Destiny Pharma plc (JPJ:DEST), a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening inf [ … ]